0001125345-24-000055.txt : 20240306 0001125345-24-000055.hdr.sgml : 20240306 20240306161933 ACCESSION NUMBER: 0001125345-24-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240304 FILED AS OF DATE: 20240306 DATE AS OF CHANGE: 20240306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spitznagel Thomas CENTRAL INDEX KEY: 0001675464 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36112 FILM NUMBER: 24726137 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MACROGENICS INC CENTRAL INDEX KEY: 0001125345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: Rockville STATE: MD ZIP: 20850 BUSINESS PHONE: 301-251-5172 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 wk-form4_1709759960.xml FORM 4 X0508 4 2024-03-04 0 0001125345 MACROGENICS INC MGNX 0001675464 Spitznagel Thomas 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 Sr VP, Technical Ops 1 Common Stock 2024-03-04 4 M 0 10000 11.50 A 18316 D Common Stock 2024-03-04 4 S 0 10000 20 D 8316 D Employee stock option (right to buy) 11.50 2024-03-04 4 M 0 10000 0 D 2030-02-20 Common Stock 10000 77000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/17/2023. 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. /s/ Lynn M. Cilinski, Attorney-in-fact 2024-03-06